National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$36.00
add to cart

Rights & Permissions

topleft topright

Emerging Safety Science: Workshop Summary (2008)
Board on Health Sciences Policy (HSP)

Citation Manager

Robinson, Sally, Pool, Robert, Giffin, Robert. "4 Screening Technologies II: Toxicogenomics." Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press, 2008.

Please select a format:

BibTeX EndNote RefMan


Page
49
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Emerging Safety Science: Workshop Summary

it was suggested that a level of transcriptional change greater than 3 percent indicates drug-related pathology. Information gained from studying gene expression changes can be used to

  • identify toxicological issues early prior to large financial investments;

  • select the compounds that are least likely to fail because of toxicological issues;

  • understand mechanisms of toxicity; and

  • bridge preclinical and clinical data by understanding the mechanisms and commonalities in responses.

These gene expression assays, however, apply only to rat models, and the next challenge is to transition from prediction of toxicity in rats to prediction of toxicity in humans.

Page
49